Premium
Epigenetic control of somatostatin and cortistatin expression by β amyloid peptide
Author(s) -
Rubio Alicia,
SánchezMut José V.,
García Esther,
Velasquez Zahady D.,
Oliver Jorge,
Esteller Manel,
Avila Jesús
Publication year - 2012
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.22731
Subject(s) - somatostatin , epigenetics , amyloid (mycology) , neuropeptide , h3k4me3 , senile plaques , neuroscience , alzheimer's disease , toxicity , biology , gene expression , medicine , microbiology and biotechnology , gene , disease , biochemistry , receptor , promoter , botany
β Amyloid, present in senile plaques, has been related largely to neuronal loss in the brain of patients with Alzheimer's disease. However, how neurons respond to β amyloid insults is still poorly understood. Here we show that β amyloid increases somatostatin and cortistatin gene expression mainly through an increase in histone 3 lysine 4 methylation (H3K4me3), a modification associated with transcriptional activation. Somatostatin and cortistatin partially decreased β amyloid toxicity in primary cortical neurons in culture. Thus we suggest that neurons respond to β amyloid insults by releasing somatostatin and cortistatin, which will act as a protective agent against β amyloid toxicity. Our results suggest a relevant function for both neuropeptides against β amyloid toxicity, providing new insights into Alzheimer's disease. © 2011 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom